Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,20/135,233/18800,3.45351583329854e-16,1.01740576448975e-12,6.52169200519746e-13,CD274/CD276/CD300A/CD55/CD74/CSF1/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/LGALS9/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VCAM1/VSIG4,20
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,19/135,230/18800,4.06185916008182e-15,3.9887456952003494e-12,2.55683345024098e-12,CD274/CD276/CD300A/CD55/CD74/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/LGALS9/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VCAM1/VSIG4,19
GO:0070661,GO:0070661,leukocyte proliferation,21/135,330/18800,2.42986574568633e-14,1.46206873247439e-11,9.37203453767485e-12,CD274/CD276/CD300A/CD55/CD74/CSF1/CX3CL1/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/LGALS9/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VCAM1/VSIG4,21
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,20/135,291/18800,2.4814472716809102e-14,1.46206873247439e-11,9.37203453767485e-12,CD27/CD274/CD276/CD55/CD74/CD83/CX3CL1/FSTL3/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/IL4R/LGALS9/PLAUR/TFRC/TGFBR2/TNFRSF14/VCAM1,20
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,22/135,381/18800,4.0728289086420305e-14,1.8069248807209397e-11,1.1582603480235e-11,CD27/CD274/CD276/CD300A/CD55/CD74/CD83/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/IL4R/JAM2/LGALS9/PODXL2/TFRC/TGFBR2/TNFRSF14/TNFRSF21/VCAM1/VSIG4,22
GO:0050863,GO:0050863,regulation of T cell activation,21/135,342/18800,4.9067885423515e-14,1.8069248807209397e-11,1.1582603480235e-11,CD27/CD274/CD276/CD300A/CD55/CD74/CD83/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/IL4R/LGALS9/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/VCAM1/VSIG4,21
GO:0042098,GO:0042098,T cell proliferation,17/135,204/18800,1.0762103088367199e-13,3.2550280220234596e-11,2.08651169168188e-11,CD274/CD276/CD55/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/LGALS9/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VCAM1/VSIG4,17
GO:0050870,GO:0050870,positive regulation of T cell activation,17/135,223/18800,4.63431568233541e-13,9.536538544970109e-11,6.1130346766986e-11,CD27/CD274/CD276/CD55/CD74/CD83/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/IL4R/LGALS9/TFRC/TGFBR2/TNFRSF14/VCAM1,17
GO:0002274,GO:0002274,myeloid leukocyte activation,17/135,232/18800,8.82040477255371e-13,1.5285242623496002e-10,9.798022391307339e-11,CD300A/CD300LF/CD74/CD93/CHGA/CSF1/CX3CL1/HAVCR2/IFNGR1/IL15/IL4R/LGALS9/LTBR/NECTIN2/PTGDS/TGFBR2/VSIG4,17
GO:0051251,GO:0051251,positive regulation of lymphocyte activation,19/135,371/18800,2.08173279111969e-11,2.7876294557448104e-09,1.7869036494108702e-09,AXL/CD27/CD274/CD276/CD55/CD74/CD83/HAVCR2/HLA-E/IGFBP2/IL15/IL2RA/IL4R/LGALS9/TFRC/TGFBR2/TNFRSF14/TNFRSF4/VCAM1,19
GO:0002683,GO:0002683,negative regulation of immune system process,20/135,425/18800,2.70995195548027e-11,3.3264660253520302e-09,2.1323043018121e-09,AMBP/AXL/CCN3/CD274/CD300A/CD300LF/CD55/CD59/CD74/CX3CL1/FSTL3/HAVCR2/HLA-E/IL2RA/IL4R/LGALS9/NBL1/TNFRSF14/TNFRSF21/VSIG4,20
GO:0050866,GO:0050866,negative regulation of cell activation,14/135,216/18800,5.13416910520089e-10,5.81740853227762e-08,3.72902808693538e-08,AXL/CD274/CD300A/CD300LF/CD74/CX3CL1/HAVCR2/IL2RA/IL4R/LGALS9/THBD/TNFRSF14/TNFRSF21/VSIG4,14
GO:0046718,GO:0046718,viral entry into host cell,12/135,146/18800,6.225781897626131e-10,6.79301980385429e-08,4.35440652021103e-08,AXL/BSG/CD55/CD74/EPHA2/LGALS9/NECTIN2/NECTIN4/SCARB2/TFRC/TNFRSF14/TNFRSF4,12
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,18/135,486/18800,1.26549375638452e-08,1.18593284969648e-06,7.60197067336791e-07,AXL/CD300LF/CD74/CSF1/CX3CL1/EDA2R/IFNGR1/IL10RB/IL15/IL2RA/IL4R/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/YAP1,18
GO:0050900,GO:0050900,leukocyte migration,16/135,384/18800,1.69949732960765e-08,1.47256445088945e-06,9.439313341536e-07,B4GALT1/BSG/CCN3/CD300A/CD74/CHGA/CSF1/CX3CL1/JAM2/LGALS9/NBL1/PGF/PODXL2/TNFRSF11A/TNFRSF14/VCAM1,16
GO:0050868,GO:0050868,negative regulation of T cell activation,10/135,125/18800,2.29346918812245e-08,1.89336105215964e-06,1.21366696236624e-06,CD274/CD300A/CD74/HAVCR2/IL2RA/IL4R/LGALS9/TNFRSF14/TNFRSF21/VSIG4,10
GO:0044706,GO:0044706,multi-multicellular organism process,12/135,213/18800,4.47165244063746e-08,3.46670739213631e-06,2.2222006865661e-06,ADM/AMBP/B4GALT1/BSG/HAVCR2/IGFBP2/LGALS9/PGF/SPP1/TGFBR2/THBD/TIMP1,12
GO:0048771,GO:0048771,tissue remodeling,11/135,174/18800,5.15888248950241e-08,3.89694046514721e-06,2.49798520544327e-06,ACVRL1/AXL/CST3/CTHRC1/EPHA2/IL15/RSPO3/SPP1/TFRC/TIMP1/TNFRSF11A,11
GO:0045621,GO:0045621,positive regulation of lymphocyte differentiation,9/135,107/18800,7.67718906133912e-08,5.4638564792185e-06,3.50239701422732e-06,AXL/CD27/CD74/CD83/IL15/IL2RA/IL4R/LGALS9/TGFBR2,9
GO:0002507,GO:0002507,tolerance induction,6/135,31/18800,7.78961208849889e-08,5.4638564792185e-06,3.50239701422732e-06,CD274/HAVCR2/HLA-E/IL2RA/LGALS9/TGFBR2,6
GO:0007565,GO:0007565,female pregnancy,11/135,185/18800,9.6581968326284e-08,6.46660178839165e-06,4.14516868845343e-06,ADM/AMBP/BSG/HAVCR2/IGFBP2/LGALS9/PGF/SPP1/TGFBR2/THBD/TIMP1,11
GO:0032496,GO:0032496,response to lipopolysaccharide,14/135,333/18800,1.26168167137019e-07,8.25980934190353e-06,5.29463606652193e-06,ADM/AXL/CD274/CD55/CX3CL1/HAVCR2/IL18BP/LGALS9/SPON2/THBD/TIMP4/TNFRSF11A/TNFRSF1B/VCAM1,14
GO:0046631,GO:0046631,alpha-beta T cell activation,10/135,158/18800,2.11497880637317e-07,1.24614551271507e-05,7.98794100764942e-06,CD274/CD300A/CD55/CD83/HLA-E/IL15/IL4R/LGALS9/TGFBR2/TNFRSF14,10
GO:0007568,GO:0007568,aging,10/135,163/18800,2.8274949289743e-07,1.54255556680709e-05,9.88796472237795e-06,ADM/CX3CL1/GFRA1/IGFBP2/IL15/TFRC/TGFBR2/TIMP1/TNFRSF1B/VCAM1,10
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,14/135,373/18800,4.99227420983609e-07,2.53573100382364e-05,1.62543374454554e-05,AXL/CD300A/CD74/EFEMP1/EFNA1/EPHA2/EPHB4/EPHB6/GFRA1/IL15/ROR1/SPINK1/TNFRSF14/TNFRSF1A,14
GO:1903131,GO:1903131,mononuclear cell differentiation,15/135,433/18800,5.28343452396985e-07,2.63813527247715e-05,1.69107609919749e-05,AXL/CD27/CD74/CD79B/CD83/CSF1/DLL1/IL15/IL2RA/IL4R/LGALS9/LTBR/LY6D/TGFBR2/VCAM1,15
GO:0050777,GO:0050777,negative regulation of immune response,10/135,179/18800,6.7155285912046e-07,3.19095923059496e-05,2.0454428340613e-05,AMBP/CD300A/CD55/CD59/HAVCR2/HLA-E/IL4R/LGALS9/TNFRSF14/VSIG4,10
GO:0002443,GO:0002443,leukocyte mediated immunity,15/135,457/18800,1.03940941682272e-06,4.62400649238513e-05,2.96404317981167e-05,CD27/CD300A/CD55/CD74/CHGA/HAVCR2/HLA-E/IL4R/LGALS9/NECTIN2/PTGDS/SPON2/TFRC/TNFRSF1B/ULBP2,15
GO:0031099,GO:0031099,regeneration,10/135,188/18800,1.05162401557978e-06,4.62400649238513e-05,2.96404317981167e-05,ADM/AXL/CCN3/FOLR1/NEFL/PGF/SPP1/TGFBR2/TGFBR3/YAP1,10
GO:0043123,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,10/135,188/18800,1.05162401557978e-06,4.62400649238513e-05,2.96404317981167e-05,CD74/CX3CL1/EDA2R/LGALS9/LTBR/ROR1/SHISA5/TFRC/TNFRSF19/TNFRSF1A,10
GO:0070227,GO:0070227,lymphocyte apoptotic process,7/135,75/18800,1.11312587302379e-06,4.75256351004071e-05,3.04644975774933e-05,CD27/CD274/CD74/EFNA1/IL2RA/LGALS9/TNFRSF21,7
GO:0034612,GO:0034612,response to tumor necrosis factor,11/135,249/18800,1.86120713165044e-06,7.21462659189763e-05,4.62466148778517e-05,CX3CL1/EDA2R/IL18BP/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF21/TNFRSF4/VCAM1,11
GO:0002702,GO:0002702,positive regulation of production of molecular mediator of immune response,8/135,120/18800,2.45528549775899e-06,9.15603933721264e-05,5.86913015720137e-05,CD55/CD74/HLA-E/IL4R/SPON2/TFRC/TNFRSF14/TNFRSF4,8
GO:0032102,GO:0032102,negative regulation of response to external stimulus,14/135,429/18800,2.60164167622541e-06,9.58054547270007e-05,6.14124364098472e-05,CCN3/CX3CL1/HAVCR2/HLA-E/IL2RA/LGALS9/NBL1/SEMA3F/SIGLEC10/SPP1/THBD/TNFRSF1A/TNFRSF1B/VSIG4,14
GO:0060326,GO:0060326,cell chemotaxis,12/135,315/18800,2.92063908862883e-06,0.0001062247253716,6.80913128654987e-05,BSG/CCN3/CD74/CHGA/CSF1/CX3CL1/EPHA2/LGALS9/NBL1/PGF/TNFRSF11A/VCAM1,12
GO:0002685,GO:0002685,regulation of leukocyte migration,10/135,218/18800,3.98745629454669e-06,0.0001365935609736,8.75580978263986e-05,CCN3/CD300A/CD74/CSF1/CX3CL1/JAM2/LGALS9/NBL1/PGF/TNFRSF14,10
GO:0001819,GO:0001819,positive regulation of cytokine production,14/135,475/18800,8.3613731869515e-06,0.000262867984307,0.0001685015056443,CD274/CD276/CD55/CD74/CD83/CX3CL1/HAVCR2/HLA-E/IFNGR1/IL15/IL4R/LGALS9/SPON2/TNFRSF14,14
GO:0009991,GO:0009991,response to extracellular stimulus,14/135,479/18800,9.19209932706209e-06,0.0002850518380792,0.0001827216198642,ADM/AXL/DSC2/FGF23/FOLR1/GDF15/IGFBP2/IL15/LRP11/SPINK1/SPP1/TFRC/TGFBR2/VCAM1,14
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,10/135,251/18800,1.37470630239683e-05,0.0003857033111296,0.0002472404116791,AMBP/CD27/COL6A3/CST3/PLAUR/SPINK1/TFPI2/TIMP1/TIMP4/WFDC2,10
GO:0031348,GO:0031348,negative regulation of defense response,10/135,268/18800,2.41657180289265e-05,0.0006300195160461,0.000403850005998,CCN3/CX3CL1/HAVCR2/HLA-E/IL2RA/LGALS9/SIGLEC10/TNFRSF1A/TNFRSF1B/VSIG4,10
GO:0051048,GO:0051048,negative regulation of secretion,8/135,167/18800,2.78961520068156e-05,0.0007208952965971,0.0004621024626059,CCN3/CD300A/CD74/CHGA/FGF23/LGALS9/TNFRSF1A/TNFRSF1B,8
GO:0043303,GO:0043303,mast cell degranulation,5/135,50/18800,2.89730630289345e-05,0.000735815893821,0.0004716667429574,CD300A/CHGA/IL4R/LGALS9/PTGDS,5
GO:2000106,GO:2000106,regulation of leukocyte apoptotic process,6/135,85/18800,3.36901885455113e-05,0.0008483016705562,0.0005437714642433,AXL/CD27/CD274/CD74/EFNA1/LGALS9,6
GO:0002279,GO:0002279,mast cell activation involved in immune response,5/135,52/18800,3.51333814397865e-05,0.0008697726195093,0.0005575345979918,CD300A/CHGA/IL4R/LGALS9/PTGDS,5
GO:0048013,GO:0048013,ephrin receptor signaling pathway,5/135,52/18800,3.51333814397865e-05,0.0008697726195093,0.0005575345979918,EFNA1/EFNA4/EPHA2/EPHB4/EPHB6,5
GO:0034125,GO:0034125,negative regulation of MyD88-dependent toll-like receptor signaling pathway,2/135,2/18800,5.1185384464769e-05,0.0012113235747028,0.0007764728241744,CD300A/CD300LF,2
GO:0001503,GO:0001503,ossification,12/135,420/18800,5.13969609089802e-05,0.0012113235747028,0.0007764728241744,ATRAID/CHRDL1/CSF1/CTHRC1/EPHA2/FGF23/FSTL3/PHOSPHO1/SPP1/TNC/TNFRSF11A/YAP1,12
GO:0001906,GO:0001906,cell killing,8/135,185/18800,5.77641889554679e-05,0.0013191728733551,0.0008456055078425,CD55/CD59/CHGA/HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,8
GO:0052548,GO:0052548,regulation of endopeptidase activity,12/135,426/18800,5.88857987862068e-05,0.001334442794032,0.0008553937086838,AMBP/CD27/COL6A3/CST3/EFNA1/LGALS9/PLAUR/SPINK1/TFPI2/TIMP1/TIMP4/WFDC2,12
GO:0071706,GO:0071706,tumor necrosis factor superfamily cytokine production,8/135,187/18800,6.23074827496614e-05,0.0013905897286401,0.0008913845618252,AXL/CD274/CX3CL1/HAVCR2/HLA-E/IFNGR1/LGALS9/SPON2,8
GO:0042060,GO:0042060,wound healing,12/135,429/18800,6.29719851747622e-05,0.0013948531452996,0.0008941174626317,ACVRL1/AXL/B4GALT1/CD59/CX3CL1/PLAUR/SDC1/TFPI2/TGFBR2/THBD/TIMP1/YAP1,12
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,11/135,370/18800,7.50100503258572e-05,0.0016157625832788,0.0010357230408411,CD27/CD274/CD55/CD74/HAVCR2/HLA-E/IL18BP/IL4R/NECTIN2/TFRC/TNFRSF1B,11
GO:0032103,GO:0032103,positive regulation of response to external stimulus,12/135,442/18800,8.36434645130478e-05,0.0017326120592136,0.001110624945235,CD74/CSF1/CX3CL1/HAVCR2/HLA-E/IL15/LGALS9/NECTIN2/PGF/THBD/TNFRSF11A/TNFRSF1A,12
GO:0002367,GO:0002367,cytokine production involved in immune response,6/135,100/18800,8.41016715775826e-05,0.0017326120592136,0.001110624945235,CD55/CD74/HLA-E/SPON2/TNFRSF14/TNFRSF1B,6
GO:0031341,GO:0031341,regulation of cell killing,6/135,100/18800,8.41016715775826e-05,0.0017326120592136,0.001110624945235,CD55/CD59/HAVCR2/HLA-E/LGALS9/NECTIN2,6
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,3/135,13/18800,9.82540364318912e-05,0.0019043183640023,0.0012206907296316,CST3/TNFRSF1A/TNFRSF1B,3
GO:0031100,GO:0031100,animal organ regeneration,5/135,65/18800,0.0001036279619484,0.0019823894538978,0.0012707352271743,ADM/AXL/PGF/TGFBR2/TGFBR3,5
GO:0090092,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,9/135,267/18800,0.0001352648720111,0.0024905644559053,0.0015964814499211,ACVRL1/CCN3/CHRDL1/FOLR1/FSTL3/GDF15/NBL1/TGFBR2/TGFBR3,9
GO:0014028,GO:0014028,notochord formation,2/135,3/18800,0.0001528318576039,0.0027792756327232,0.001781548749457,EFNA1/EPHA2,2
GO:0033674,GO:0033674,positive regulation of kinase activity,12/135,476/18800,0.0001673688923102,0.003006516809426,0.0019272130475257,AXL/CD300A/CD74/CSF1/EFNA1/EPHA2/EPHB4/EPHB6/ROR1/TGFBR2/TNFRSF10A/TNFRSF11A,12
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,5/135,72/18800,0.0001686305895145,0.0030108225255144,0.0019299730627694,HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,5
GO:0045780,GO:0045780,positive regulation of bone resorption,3/135,16/18800,0.0001893720946446,0.0033406598252882,0.0021414026964544,SPP1/TFRC/TNFRSF11A,3
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,8/135,221/18800,0.0001980973292784,0.0034532232665943,0.0022135572016544,CD27/CX3CL1/IL19/LTBR/TNFRSF10A/TNFRSF1A/TNFRSF1B/YAP1,8
GO:0043299,GO:0043299,leukocyte degranulation,5/135,76/18800,0.0002176194523373,0.0037491631964084,0.0024032582178714,CD300A/CHGA/IL4R/LGALS9/PTGDS,5
GO:0002347,GO:0002347,response to tumor cell,4/135,42/18800,0.0002303431187676,0.0038999472867218,0.0024999126138489,CD274/HAVCR2/IGFBPL1/NECTIN2,4
GO:0032418,GO:0032418,lysosome localization,5/135,79/18800,0.0002609524628315,0.0043189098623701,0.0027684726098159,CD300A/CHGA/IL4R/LGALS9/PTGDS,5
GO:1990849,GO:1990849,vacuolar localization,5/135,79/18800,0.0002609524628315,0.0043189098623701,0.0027684726098159,CD300A/CHGA/IL4R/LGALS9/PTGDS,5
GO:0001946,GO:0001946,lymphangiogenesis,3/135,18/18800,0.0002730554243854,0.0044319221120148,0.0028409148065011,ACVRL1/CLEC14A/EPHA2,3
GO:0001570,GO:0001570,vasculogenesis,5/135,80/18800,0.0002767601746776,0.004455385107105,0.0028559548655255,ADM/EPHA2/TGFBR2/TGFBR3/YAP1,5
GO:0031645,GO:0031645,negative regulation of nervous system process,3/135,19/18800,0.0003225535807556,0.0050012781521371,0.0032058788026348,CCN3/JAM2/TNFRSF21,3
GO:0045953,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,3/135,19/18800,0.0003225535807556,0.0050012781521371,0.0032058788026348,HAVCR2/HLA-E/LGALS9,3
GO:0051346,GO:0051346,negative regulation of hydrolase activity,10/135,371/18800,0.0003514384705439,0.0052530444302249,0.0033672639825002,AMBP/CD27/COL6A3/CST3/PLAUR/SPINK1/TFPI2/TIMP1/TIMP4/WFDC2,10
GO:0042476,GO:0042476,odontogenesis,6/135,130/18800,0.0003530559393022,0.0052530444302249,0.0033672639825002,ADM/BSG/CSF1/KLK4/RELT/SDC1,6
GO:0002837,GO:0002837,regulation of immune response to tumor cell,3/135,20/18800,0.0003774862293485,0.0054781991707423,0.0035115908501488,CD274/HAVCR2/NECTIN2,3
GO:0034103,GO:0034103,regulation of tissue remodeling,5/135,86/18800,0.0003874042131027,0.0055672820087842,0.0035686940092753,CST3/IL15/SPP1/TFRC/TNFRSF11A,5
GO:0002040,GO:0002040,sprouting angiogenesis,7/135,186/18800,0.0003955521538694,0.0056567798315506,0.0036260631785478,ACVRL1/CLEC14A/DLL1/EPHA2/EPHB4/PGF/RSPO3,7
GO:0071496,GO:0071496,cellular response to external stimulus,9/135,309/18800,0.0003986983522713,0.0056742287236301,0.0036372481259843,AXL/DSC2/FGF23/FOLR1/IL15/LTBR/TNFRSF10A/TNFRSF1A/VCAM1,9
GO:0002440,GO:0002440,production of molecular mediator of immune response,9/135,312/18800,0.0004276384890494,0.0060568412920183,0.0038825073347915,CD55/CD74/HLA-E/IL4R/SPON2/TFRC/TNFRSF14/TNFRSF1B/TNFRSF4,9
GO:0060070,GO:0060070,canonical Wnt signaling pathway,9/135,313/18800,0.0004376614726045,0.0060878464196313,0.0039023819905022,CTHRC1/FOLR1/IGFBP2/IGFBP4/IGFBP6/RSPO3/SDC1/WNT9A/YAP1,9
GO:1903902,GO:1903902,positive regulation of viral life cycle,3/135,21/18800,0.0004380934965926,0.0060878464196313,0.0039023819905022,AXL/CD74/LGALS9,3
GO:0006959,GO:0006959,humoral immune response,9/135,317/18800,0.000479709824281,0.0065125582595948,0.0041746273333022,CD55/CD59/CD83/HLA-E/REG1A/SPON2/TNFRSF21/VSIG4/WFDC2,9
GO:0003007,GO:0003007,heart morphogenesis,8/135,254/18800,0.000503650059108,0.0067271305208962,0.0043121707058591,ACVRL1/DLL1/EFNA1/EPHB4/FOLR1/TGFBR2/TGFBR3/YAP1,8
GO:0002834,GO:0002834,regulation of response to tumor cell,3/135,22/18800,0.0005046096161055,0.0067271305208962,0.0043121707058591,CD274/HAVCR2/NECTIN2,3
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/135,5/18800,0.0005046489630407,0.0067271305208962,0.0043121707058591,TNFRSF1A/TNFRSF1B,2
GO:0051216,GO:0051216,cartilage development,7/135,195/18800,0.0005248831079334,0.0069653407025767,0.0044648662666318,ACVRL1/CCN3/EFEMP1/MATN3/TGFBR2/TIMP1/WNT9A,7
GO:0071216,GO:0071216,cellular response to biotic stimulus,8/135,256/18800,0.0005303690738105,0.0070065797822687,0.0044913010073927,AXL/CD274/CD55/CX3CL1/HAVCR2/IGFBPL1/SPON2/TNFRSF1B,8
GO:0030101,GO:0030101,natural killer cell activation,5/135,93/18800,0.0005554426032849,0.0073050620949889,0.0046826317213028,AXL/HAVCR2/HLA-E/IL15/ULBP2,5
GO:0061448,GO:0061448,connective tissue development,8/135,260/18800,0.000587256426176,0.0075879711908538,0.0048639798179125,ACVRL1/CCN3/CSF1/EFEMP1/MATN3/TGFBR2/TIMP1/WNT9A,8
GO:0060562,GO:0060562,epithelial tube morphogenesis,9/135,328/18800,0.0006127780390693,0.0078488874047746,0.0050312302155164,ACVRL1/ADM/CSF1/CTHRC1/DLL1/EPHA2/FOLR1/TGFBR2/YAP1,9
GO:0002064,GO:0002064,epithelial cell development,7/135,203/18800,0.0006662675475413,0.0083170516739691,0.0053313290824671,B4GALT1/COL18A1/DLL1/EPHA2/SDC1/TNFRSF1A/YAP1,7
GO:0061564,GO:0061564,axon development,11/135,479/18800,0.0006866070550056,0.0084989259833895,0.0054479126788154,BSG/EFNA1/EFNA4/EPHA2/EPHB4/EPHB6/FOLR1/NEFL/SEMA3F/SPP1/TNFRSF21,11
GO:0001911,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,3/135,25/18800,0.0007418668336142,0.0089138254017889,0.005713868142641,HAVCR2/HLA-E/LGALS9,3
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/135,6/18800,0.0007534088679719,0.0089138254017889,0.005713868142641,HAVCR2/LGALS9,2
GO:1901215,GO:1901215,negative regulation of neuron death,7/135,209/18800,0.0007909150899774,0.0092830113747948,0.0059505207440533,AXL/CHGA/CSF1/CX3CL1/HYOU1/NEFL/TNFRSF1B,7
GO:1901652,GO:1901652,response to peptide,11/135,491/18800,0.0008406327099976,0.0097500156049335,0.0062498760121666,ADM/BSG/GDF15/MMP3/NEFL/REG1A/SPINK1/TGFBR3/TIMP1/TIMP4/VCAM1,11
GO:0031102,GO:0031102,neuron projection regeneration,4/135,59/18800,0.0008524229595542,0.009771354236758,0.0062635543290613,ADM/FOLR1/NEFL/SPP1,4
GO:0051092,GO:0051092,positive regulation of NF-kappaB transcription factor activity,6/135,154/18800,0.0008640939722639,0.009866747450735,0.0063247025142454,CX3CL1/EDA2R/LGALS9/ROR1/TFRC/TNFRSF11A,6
GO:0045765,GO:0045765,regulation of angiogenesis,9/135,345/18800,0.000876768055377,0.0099728134793075,0.0063926921005744,ACVRL1/ADM/DLL1/EFNA1/EPHA2/HSPB6/HSPG2/PGF/TGFBR2,9
GO:0050830,GO:0050830,defense response to Gram-positive bacterium,5/135,104/18800,0.0009230143547173,0.010418391911867,0.0066783131775072,CHGA/EPHA2/HAVCR2/HLA-E/TNFRSF14,5
GO:0002418,GO:0002418,immune response to tumor cell,3/135,27/18800,0.0009336194432582,0.0104978735871705,0.00672926187708,CD274/HAVCR2/NECTIN2,3
GO:0016064,GO:0016064,immunoglobulin mediated immune response,7/135,216/18800,0.0009589189561926,0.0107413507412299,0.0068853336298161,CD27/CD55/CD74/HLA-E/IL4R/NECTIN2/TFRC,7
GO:0002712,GO:0002712,regulation of B cell mediated immunity,4/135,62/18800,0.0010276222783631,0.0112055621530179,0.0071828986681366,CD55/HLA-E/NECTIN2/TFRC,4
GO:0002889,GO:0002889,regulation of immunoglobulin mediated immune response,4/135,62/18800,0.0010276222783631,0.0112055621530179,0.0071828986681366,CD55/HLA-E/NECTIN2/TFRC,4
GO:0043305,GO:0043305,negative regulation of mast cell degranulation,2/135,7/18800,0.0010498082668815,0.0112055621530179,0.0071828986681366,CD300A/LGALS9,2
GO:0061518,GO:0061518,microglial cell proliferation,2/135,7/18800,0.0010498082668815,0.0112055621530179,0.0071828986681366,CSF1/CX3CL1,2
GO:0090027,GO:0090027,negative regulation of monocyte chemotaxis,2/135,7/18800,0.0010498082668815,0.0112055621530179,0.0071828986681366,CCN3/NBL1,2
GO:0001666,GO:0001666,response to hypoxia,8/135,286/18800,0.0010889273867105,0.0115811555279761,0.0074236584904381,ACVRL1/ADM/HYOU1/PGF/TFRC/TGFBR2/TGFBR3/VCAM1,8
GO:0060760,GO:0060760,positive regulation of response to cytokine stimulus,4/135,64/18800,0.0011575798544964,0.0121793937548092,0.0078071363119047,AXL/CD300LF/CD74/CSF1,4
GO:0050920,GO:0050920,regulation of chemotaxis,7/135,225/18800,0.001214925578421,0.0126472464806659,0.008107035475869,CCN3/CD74/CSF1/LGALS9/NBL1/PGF/SEMA3F,7
GO:0003170,GO:0003170,heart valve development,4/135,65/18800,0.0012266914540078,0.0127247641672782,0.0081567252353224,EFNA1/TGFBR2/TNFRSF1A/TNFRSF1B,4
GO:0060389,GO:0060389,pathway-restricted SMAD protein phosphorylation,4/135,66/18800,0.0012986405339815,0.0132840104621861,0.0085152087644842,ACVRL1/GDF15/TGFBR2/TGFBR3,4
GO:0008037,GO:0008037,cell recognition,7/135,228/18800,0.0013112269572138,0.0133663481520832,0.0085679882033934,B4GALT1/BSG/COLEC12/FOLR1/HAVCR2/SPON2/TNFRSF21,7
GO:0002526,GO:0002526,acute inflammatory response,5/135,113/18800,0.0013383478240261,0.0135957678951066,0.008715048988395,B4GALT1/HLA-E/TFRC/TNFRSF11A/VCAM1,5
GO:0071295,GO:0071295,cellular response to vitamin,3/135,31/18800,0.0014049937555036,0.0137512013412416,0.0088146836767739,FGF23/FOLR1/IL15,3
GO:0033002,GO:0033002,muscle cell proliferation,7/135,233/18800,0.001484913596671,0.0143899850519504,0.0092241516358305,CCN3/CX3CL1/IL15/OGN/TGFBR2/TGFBR3/YAP1,7
GO:0071772,GO:0071772,response to BMP,6/135,173/18800,0.0015720558352951,0.0147964105136723,0.0094846751925994,ACVRL1/CHRDL1/FSTL3/GDF15/NBL1/TGFBR3,6
GO:0003143,GO:0003143,embryonic heart tube morphogenesis,4/135,70/18800,0.0016160417669627,0.0150184827932876,0.0096270261661335,DLL1/FOLR1/TGFBR2/YAP1,4
GO:0198738,GO:0198738,cell-cell signaling by wnt,10/135,454/18800,0.0016408233921425,0.0152008355762643,0.0097439164697245,CTHRC1/FOLR1/IGFBP2/IGFBP4/IGFBP6/ROR1/RSPO3/SDC1/WNT9A/YAP1,10
GO:0001649,GO:0001649,osteoblast differentiation,7/135,241/18800,0.0017996364018757,0.0162132380425869,0.010392878496588,ATRAID/CTHRC1/EPHA2/FGF23/SPP1/TNC/YAP1,7
GO:0006909,GO:0006909,phagocytosis,8/135,310/18800,0.0018124961678006,0.0162298289068108,0.01040351343796,AXL/CD300A/CD300LF/CD302/CD93/COLEC12/IL15/SPON2,8
GO:0033006,GO:0033006,regulation of mast cell activation involved in immune response,3/135,34/18800,0.00184127901604,0.0164375999431936,0.0105366971444204,CD300A/IL4R/LGALS9,3
GO:0150076,GO:0150076,neuroinflammatory response,4/135,73/18800,0.0018868910718218,0.0166930363290906,0.0107004349070599,CX3CL1/IFNGR1/MMP3/TNFRSF1B,4
GO:0033280,GO:0033280,response to vitamin D,3/135,35/18800,0.0020033966221259,0.0174615575407779,0.01119306614791,FGF23/IL15/SPP1,3
GO:0042177,GO:0042177,negative regulation of protein catabolic process,5/135,124/18800,0.0020164416968955,0.0175130792978879,0.0112260922072429,ATRAID/CST3/EFNA1/TIMP1/TIMP4,5
GO:0006898,GO:0006898,receptor-mediated endocytosis,7/135,246/18800,0.0020211972034222,0.0175130792978879,0.0112260922072429,ADM/DLL1/FOLR1/HSPG2/SCARB2/TFRC/TGFBR2,7
GO:0060249,GO:0060249,anatomical structure homeostasis,8/135,319/18800,0.0021656763689373,0.0185467516944458,0.011888688512465,CSF1/CX3CL1/JAM2/SPP1/TFF3/TFRC/TNFRSF11A/YAP1,8
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,6/135,185/18800,0.0022052176601446,0.0185632418818543,0.0118992589188004,ADM/CSF1/EPHA2/RSPO3/TGFBR2/YAP1,6
GO:0050852,GO:0050852,T cell receptor signaling pathway,5/135,127/18800,0.0022383794574885,0.0186806398916747,0.0119745124399416,BTN2A1/CD276/CD300A/NECTIN2/TNFRSF21,5
GO:0001667,GO:0001667,ameboidal-type cell migration,10/135,480/18800,0.0024620568969375,0.0202039543687413,0.0129509751447179,ACVRL1/CCN3/CLEC14A/EFNA1/EPHA2/EPHB4/FOLR1/SEMA3F/TGFBR2/TIMP1,10
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,5/135,131/18800,0.0025613341513501,0.0209021895010455,0.0133985521723928,HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,5
GO:0048638,GO:0048638,regulation of developmental growth,8/135,329/18800,0.0026194197016288,0.0212584309669381,0.0136269071907268,CSF1/DLL1/GDF15/SEMA3F/SPP1/TGFBR2/TGFBR3/YAP1,8
GO:0031642,GO:0031642,negative regulation of myelination,2/135,11/18800,0.0026981725814668,0.021310499798931,0.013660283931569,JAM2/TNFRSF21,2
GO:0071492,GO:0071492,cellular response to UV-A,2/135,11/18800,0.0026981725814668,0.021310499798931,0.013660283931569,MMP3/TIMP1,2
GO:0075294,GO:0075294,positive regulation by symbiont of entry into host,2/135,11/18800,0.0026981725814668,0.021310499798931,0.013660283931569,CD74/LGALS9,2
GO:0002792,GO:0002792,negative regulation of peptide secretion,3/135,40/18800,0.0029462650989877,0.0230230689167587,0.0147580611128971,CCN3/CD74/CHGA,3
GO:0035050,GO:0035050,embryonic heart tube development,4/135,84/18800,0.0031483303177472,0.0240349692213553,0.0154067012481193,DLL1/FOLR1/TGFBR2/YAP1,4
GO:0001763,GO:0001763,morphogenesis of a branching structure,6/135,199/18800,0.0031681681050818,0.0240349692213553,0.0154067012481193,ADM/CSF1/EPHA2/RSPO3/TGFBR2/YAP1,6
GO:0009612,GO:0009612,response to mechanical stimulus,6/135,201/18800,0.0033278655439904,0.024448608210962,0.0156718487620916,IGFBP2/LRP11/LTBR/TGFBR2/TNFRSF10A/TNFRSF1A,6
GO:0001894,GO:0001894,tissue homeostasis,7/135,272/18800,0.0035338653290359,0.02564228389,0.0164370090751635,CSF1/JAM2/SPP1/TFF3/TFRC/TNFRSF11A/YAP1,7
GO:0014002,GO:0014002,astrocyte development,3/135,43/18800,0.0036230041085565,0.0261602208426657,0.0167690128244336,DLL1/IFNGR1/ROR1,3
GO:0060670,GO:0060670,branching involved in labyrinthine layer morphogenesis,2/135,13/18800,0.0037906762380115,0.0269092342100774,0.0172491393049912,ADM/RSPO3,2
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,3/135,44/18800,0.0038678862440667,0.0273169571718097,0.0175104945747049,TIMP1/TIMP4/TNFRSF1B,3
GO:0060443,GO:0060443,mammary gland morphogenesis,3/135,44/18800,0.0038678862440667,0.0273169571718097,0.0175104945747049,CSF1/EPHA2/TGFBR2,3
GO:0001776,GO:0001776,leukocyte homeostasis,4/135,89/18800,0.003875929428994,0.0273169571718097,0.0175104945747049,AXL/CD74/IL2RA/LGALS9,4
GO:0070997,GO:0070997,neuron death,8/135,353/18800,0.0040134389430671,0.0280845394923414,0.0180025239751529,AXL/CHGA/CSF1/CX3CL1/HYOU1/NEFL/TNFRSF1B/TNFRSF21,8
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,7/135,279/18800,0.004059758348242,0.028341346194126,0.0181671401265809,BSG/CX3CL1/DSC2/NECTIN2/NECTIN4/TGFBR2/VCAM1,7
GO:0007520,GO:0007520,myoblast fusion,3/135,45/18800,0.0041226239473497,0.0285770591738646,0.0183182349511963,GDF15/IL4R/JAM2,3
GO:0051146,GO:0051146,striated muscle cell differentiation,7/135,281/18800,0.0042203927319075,0.0291860962164308,0.0187086349420362,CCN3/DLL1/GDF15/IL4R/JAM2/LMOD1/SDC1,7
GO:0043301,GO:0043301,negative regulation of leukocyte degranulation,2/135,14/18800,0.0044017232718494,0.0300869530368175,0.0192860948826421,CD300A/LGALS9,2
GO:0070141,GO:0070141,response to UV-A,2/135,14/18800,0.0044017232718494,0.0300869530368175,0.0192860948826421,MMP3/TIMP1,2
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/135,14/18800,0.0044017232718494,0.0300869530368175,0.0192860948826421,TNFRSF1A/TNFRSF1B,2
GO:0050673,GO:0050673,epithelial cell proliferation,9/135,443/18800,0.00473707200849,0.0320814118092224,0.0205645666865849,ACVRL1/B4GALT1/CCN3/EPHA2/IGFBP4/PGF/SPINK1/TGFBR3/YAP1,9
GO:0045747,GO:0045747,positive regulation of Notch signaling pathway,3/135,48/18800,0.0049471147455391,0.0332744293158864,0.0213293051033338,CCN3/DLL1/YAP1,3
GO:0042063,GO:0042063,gliogenesis,7/135,291/18800,0.0050969848140111,0.0338053832708897,0.0216696529059835,CSF1/CX3CL1/DLL1/IFNGR1/ROR1/TNFRSF1B/TNFRSF21,7
GO:0051271,GO:0051271,negative regulation of cellular component movement,8/135,369/18800,0.0052221976486921,0.0342441416590663,0.0219509022533194,ACVRL1/CCN3/CD300A/CD74/CX3CL1/NBL1/TGFBR3/TIMP1,8
GO:0010862,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,3/135,49/18800,0.0052423991473994,0.0342441416590663,0.0219509022533194,ACVRL1/GDF15/TGFBR2,3
GO:0060043,GO:0060043,regulation of cardiac muscle cell proliferation,3/135,49/18800,0.0052423991473994,0.0342441416590663,0.0219509022533194,TGFBR2/TGFBR3/YAP1,3
GO:0006692,GO:0006692,prostanoid metabolic process,3/135,50/18800,0.0055480816966804,0.0357650955764129,0.0229258518112284,CD74/PTGDS/TNFRSF1A,3
GO:0006693,GO:0006693,prostaglandin metabolic process,3/135,50/18800,0.0055480816966804,0.0357650955764129,0.0229258518112284,CD74/PTGDS/TNFRSF1A,3
GO:0030857,GO:0030857,negative regulation of epithelial cell differentiation,3/135,50/18800,0.0055480816966804,0.0357650955764129,0.0229258518112284,ACVRL1/DLL1/YAP1,3
GO:0021700,GO:0021700,developmental maturation,7/135,296/18800,0.0055835568501899,0.0359151931892133,0.023022066166952,ACVRL1/AXL/CX3CL1/IL15/NEFL/PHOSPHO1/SPINK1,7
GO:0034349,GO:0034349,glial cell apoptotic process,2/135,16/18800,0.005750221239051,0.0366669951736894,0.0235039801842279,DLL1/TNFRSF21,2
GO:0060046,GO:0060046,regulation of acrosome reaction,2/135,16/18800,0.005750221239051,0.0366669951736894,0.0235039801842279,B4GALT1/SPINK1,2
GO:1901741,GO:1901741,positive regulation of myoblast fusion,2/135,16/18800,0.005750221239051,0.0366669951736894,0.0235039801842279,GDF15/IL4R,2
GO:0060485,GO:0060485,mesenchyme development,7/135,301/18800,0.0061042003664947,0.0387564100855464,0.0248433200033838,ACVRL1/EFNA1/FOLR1/SEMA3F/TGFBR2/TGFBR3/YAP1,7
GO:2001234,GO:2001234,negative regulation of apoptotic signaling pathway,6/135,230/18800,0.0063779270753293,0.040234203777131,0.0257906033430425,CD74/CX3CL1/HYOU1/IL19/PLAUR/YAP1,6
GO:0048532,GO:0048532,anatomical structure arrangement,2/135,17/18800,0.0064864179837438,0.0403143193673196,0.0258419583895993,DLL1/SEMA3F,2
GO:0090594,GO:0090594,inflammatory response to wounding,2/135,17/18800,0.0064864179837438,0.0403143193673196,0.0258419583895993,SIGLEC10/TIMP1,2
GO:0002931,GO:0002931,response to ischemia,3/135,53/18800,0.0065284692683311,0.0404051900514779,0.0259002075793587,CSF1/CX3CL1/HYOU1,3
GO:0060071,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",3/135,53/18800,0.0065284692683311,0.0404051900514779,0.0259002075793587,CTHRC1/ROR1/RSPO3,3
GO:0097305,GO:0097305,response to alcohol,6/135,235/18800,0.0070599198995843,0.0406041981459571,0.0260277741357941,CD27/NEFL/SPINK1/TGFBR2/TGFBR3/VCAM1,6
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,HLA-E,1
GO:0003147,GO:0003147,neural crest cell migration involved in heart formation,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,FOLR1,1
GO:0010711,GO:0010711,negative regulation of collagen catabolic process,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CST3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,DLL1,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,NECTIN2,1
GO:0048683,GO:0048683,regulation of collateral sprouting of intact axon in response to injury,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,SPP1,1
GO:0048685,GO:0048685,negative regulation of collateral sprouting of intact axon in response to injury,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,SPP1,1
GO:0060101,GO:0060101,"negative regulation of phagocytosis, engulfment",1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CD300A,1
GO:0060311,GO:0060311,negative regulation of elastin catabolic process,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CST3,1
GO:0060611,GO:0060611,mammary gland fat development,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CSF1,1
GO:0060739,GO:0060739,mesenchymal-epithelial cell signaling involved in prostate gland development,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,TNC,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,DLL1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,VCAM1,1
GO:0086030,GO:0086030,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CHGA,1
GO:0090143,GO:0090143,nucleoid organization,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CHCHD10,1
GO:0090144,GO:0090144,mitochondrial nucleoid organization,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CHCHD10,1
GO:1902569,GO:1902569,negative regulation of activation of Janus kinase activity,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CD300A,1
GO:1905154,GO:1905154,negative regulation of membrane invagination,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,CD300A,1
GO:1905317,GO:1905317,inferior endocardial cushion morphogenesis,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,TGFBR2,1
GO:2000184,GO:2000184,positive regulation of progesterone biosynthetic process,1/135,1/18800,0.0071808510638301,0.0406041981459571,0.0260277741357941,ADM,1
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,2/135,18/18800,0.0072630883036636,0.0406788177615841,0.0260756061972637,COLEC12/HAVCR2,2
GO:0048535,GO:0048535,lymph node development,2/135,18/18800,0.0072630883036636,0.0406788177615841,0.0260756061972637,IL15/TNFRSF11A,2
GO:0090287,GO:0090287,regulation of cellular response to growth factor stimulus,7/135,314/18800,0.00762756027244,0.0423178767657408,0.0271262625210773,ACVRL1/CHRDL1/DLL1/FOLR1/FSTL3/NBL1/TGFBR3,7
GO:0040013,GO:0040013,negative regulation of locomotion,8/135,396/18800,0.0078718062279311,0.0435090828283026,0.0278898397806034,ACVRL1/CCN3/CD300A/CD74/CX3CL1/NBL1/SEMA3F/TIMP1,8
GO:0032526,GO:0032526,response to retinoic acid,4/135,109/18800,0.0079141625615251,0.0436612788506613,0.0279873992418217,IGFBP2/TFRC/WNT9A/YAP1,4
GO:0110148,GO:0110148,biomineralization,5/135,172/18800,0.0080716439906934,0.0439973490281026,0.0282028242242527,ATRAID/FGF23/KLK4/PHOSPHO1/SPP1,5
GO:0016049,GO:0016049,cell growth,9/135,484/18800,0.0082847531301881,0.0448655932381144,0.0287593790935711,ACVRL1/CCN3/IGFBP4/IGFBPL1/SEMA3F/SPP1/TGFBR2/TNC/YAP1,9
GO:0031668,GO:0031668,cellular response to extracellular stimulus,6/135,245/18800,0.0085801867685016,0.0457092770705348,0.0293001904686245,AXL/DSC2/FGF23/FOLR1/IL15/VCAM1,6
GO:0045926,GO:0045926,negative regulation of growth,6/135,245/18800,0.0085801867685016,0.0457092770705348,0.0293001904686245,ACVRL1/CCN3/GDF15/SEMA3F/SPP1/TGFBR2,6
GO:0043534,GO:0043534,blood vessel endothelial cell migration,5/135,175/18800,0.0086615793288347,0.0459765994644094,0.0294715473038019,ACVRL1/CLEC14A/EFNA1/EPHA2/EPHB4,5
GO:0071695,GO:0071695,anatomical structure maturation,6/135,246/18800,0.0087441615076286,0.0461992839394276,0.0296142907018734,ACVRL1/AXL/CX3CL1/IL15/PHOSPHO1/SPINK1,6
GO:0140253,GO:0140253,cell-cell fusion,3/135,59/18800,0.0087819412783704,0.0461992839394276,0.0296142907018734,GDF15/IL4R/JAM2,3
GO:0051656,GO:0051656,establishment of organelle localization,8/135,404/18800,0.0088234983942079,0.0463351626904396,0.0297013905980093,CD300A/CHGA/IL4R/LGALS9/NECTIN2/NEFL/PTGDS/SDC1,8
GO:1902004,GO:1902004,positive regulation of amyloid-beta formation,2/135,20/18800,0.0089354146417128,0.0464263342759895,0.0297598326691411,EFNA1/IFNGR1,2
GO:1902074,GO:1902074,response to salt,2/135,20/18800,0.0089354146417128,0.0464263342759895,0.0297598326691411,FGF23/NEFL,2
GO:0046888,GO:0046888,negative regulation of hormone secretion,3/135,60/18800,0.0091963448416102,0.0475305822866381,0.0304676687827308,CCN3/CHGA/FGF23,3
